Flora Growth Corp. (FLGC)

USD 0.46

(0.65%)

Revenue Summary of Flora Growth Corp.

  • Flora Growth Corp.'s latest annual revenue in 2023 was 76.07 Million USD , up 104.65% from previous year.
  • Flora Growth Corp.'s latest quarterly revenue in 2024 Q2 was 15.68 Million USD , down -13.02% from previous quarter.
  • Flora Growth Corp. reported a annual revenue of 37.17 Million USD in annual revenue 2022, up 313.93% from previous year.
  • Flora Growth Corp. reported a annual revenue of 8.98 Million USD in annual revenue 2021, up 8371.7% from previous year.
  • Flora Growth Corp. reported a quarterly revenue of 18.03 Million USD for 2024 Q1, up 0.31% from previous quarter.
  • Flora Growth Corp. reported a quarterly revenue of 20.1 Million USD for 2023 Q1, up 75.01% from previous quarter.

Annual Revenue Chart of Flora Growth Corp. (2023 - 2019)

Historical Annual Revenue of Flora Growth Corp. (2023 - 2019)

Year Revenue Revenue Growth
2023 76.07 Million USD 104.65%
2022 37.17 Million USD 313.93%
2021 8.98 Million USD 8371.7%
2020 106 Thousand USD 0.0%
2019 - USD 0.0%

Peer Revenue Comparison of Flora Growth Corp.

Name Revenue Revenue Difference
Collegium Pharmaceutical, Inc. 566.76 Million USD 86.578%
Embecta Corp. 1.12 Billion USD 93.213%
ANI Pharmaceuticals, Inc. 486.81 Million USD 84.374%
Dynavax Technologies Corporation 232.28 Million USD 67.251%
Esperion Therapeutics, Inc. 116.33 Million USD 34.61%
Pacira BioSciences, Inc. 674.97 Million USD 88.73%
PainReform Ltd. - USD -Infinity%
Aquestive Therapeutics, Inc. 50.58 Million USD -50.388%
Sunshine Biopharma, Inc. 24.09 Million USD -215.742%
SCYNEXIS, Inc. 140.14 Million USD 45.718%
China SXT Pharmaceuticals, Inc. 1.92 Million USD -3844.574%
Cosmos Health Inc. 53.37 Million USD -42.517%
Journey Medical Corporation 79.18 Million USD 3.928%
Sunshine Biopharma, Inc. 24.09 Million USD -215.742%
Safety Shot Inc 202.67 Thousand USD -37434.416%
Alpha Teknova, Inc. 36.68 Million USD -107.368%
Intra-Cellular Therapies, Inc. 464.37 Million USD 83.618%
Bright Green Corporation 401.49 Thousand USD -18847.125%
Procaps Group, S.A. 409.92 Million USD 81.442%
Theratechnologies Inc. 81.76 Million USD 6.963%
Harrow Health, Inc. 130.19 Million USD 41.571%
Sonoma Pharmaceuticals, Inc. 12.73 Million USD -497.338%
Biofrontera Inc. 34.07 Million USD -123.272%
DURECT Corporation 8.54 Million USD -789.927%
Supernus Pharmaceuticals, Inc. 607.52 Million USD 87.478%
Cronos Group Inc. 88.84 Million USD 14.374%
OptiNose, Inc. 70.98 Million USD -7.162%
Ironwood Pharmaceuticals, Inc. 442.73 Million USD 82.818%
Kala Pharmaceuticals, Inc. - USD -Infinity%
RedHill Biopharma Ltd. 6.51 Million USD -1067.956%
Organogenesis Holdings Inc. 433.14 Million USD 82.437%
Guardion Health Sciences, Inc. 12.24 Million USD -521.061%
Cumberland Pharmaceuticals Inc. 39.55 Million USD -92.329%
Radius Health, Inc. 2.88 Billion USD 97.361%
Universe Pharmaceuticals INC 32.3 Million USD -135.45%
ProPhase Labs, Inc. 44.38 Million USD -71.393%
Phibro Animal Health Corporation 1.01 Billion USD 92.525%
Procaps Group S.A. 409.92 Million USD 81.442%
Alvotech 91.43 Million USD 16.802%
TherapeuticsMD, Inc. 1.3 Million USD -5742.627%
Viatris Inc. 15.42 Billion USD 99.507%
Rockwell Medical, Inc. 83.61 Million USD 9.019%
Aytu BioPharma, Inc. 81 Million USD 6.088%
SIGA Technologies, Inc. 139.91 Million USD 45.631%
Tilray Brands, Inc. 788.94 Million USD 90.358%
Lifecore Biomedical, Inc. 128.26 Million USD 40.69%
Shineco, Inc. 9.8 Million USD -676.088%
PetIQ, Inc. 1.1 Billion USD 93.097%
Regencell Bioscience Holdings Limited - USD -Infinity%
Incannex Healthcare Limited 12 Thousand USD -633825.0%
Neurocrine Biosciences, Inc. 1.88 Billion USD 95.969%
Alimera Sciences, Inc. 80.75 Million USD 5.799%
Silver Spike Investment Corp. 11.72 Million USD -548.952%
Assertio Holdings, Inc. 152.06 Million USD 49.976%
Shuttle Pharmaceuticals Holdings, Inc. - USD -Infinity%
Petros Pharmaceuticals, Inc. 5.82 Million USD -1206.526%
Clever Leaves Holdings Inc. 17.41 Million USD -336.763%
Cyclo Therapeutics, Inc. 1.07 Million USD -6967.136%
Avadel Pharmaceuticals plc 27.96 Million USD -172.042%
Hempacco Co., Inc. 4.04 Million USD -1780.322%
Talphera, Inc. 651 Thousand USD -11585.253%
Alvotech 91.43 Million USD 16.802%
Eagle Pharmaceuticals, Inc. 316.61 Million USD 75.973%
Lantheus Holdings, Inc. 1.29 Billion USD 94.132%
Currenc Group, Inc. 53.25 Million USD -42.842%
Kamada Ltd. 144.75 Million USD 47.45%
Indivior PLC 1.09 Billion USD 93.04%
Evoke Pharma, Inc. 5.18 Million USD -1368.374%
Cyclo Therapeutics, Inc. 1.07 Million USD -6967.136%
Evolus, Inc. 202.08 Million USD 62.357%
HUTCHMED (China) Limited 837.99 Million USD 90.922%
Amphastar Pharmaceuticals, Inc. 644.39 Million USD 88.195%
Akanda Corp. 2.16 Million USD -3421.721%